Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HeartScore is a medical technology company that develops artificial intelligence software to automate the analysis and reporting of cardiac CT scans. The company's primary focus is on coronary artery calcium (CAC) scoring, a critical metric for assessing cardiovascular risk. By leveraging deep learning algorithms, HeartScore's platform can identify and quantify calcium deposits in the coronary arteries from non-gated CT scans, which are often performed for non-cardiac reasons. This automated approach aims to improve the speed and accuracy of risk assessment, enabling clinicians to identify at-risk patients earlier and implement preventative measures. The technology is designed to integrate into existing clinical workflows, providing standardized and reproducible results.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HeartScore.